Galapagos reported €-70145000 in EBITDA for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
AstraZeneca AZN:LN 2784M 588M
Biogen BIIB:US $ 991.8M 155.8M
Gilead Sciences GILD:US $ 4370M 1605M
GlaxoSmithKline GSK:LN 3660M 1034M
GRIFOLS GRF:SM € 330.18M 44.07M
H. Lundbeck A/S LUN:DC 933M 62M
Hikma Pharmaceutical HIK:LN 358M 9M
Merck MRK:GR € 1551M 25M
Neurocrine Biosciences NBIX:US $ 47.3M 23.1M
Novartis NOVN:VX SF 4837M 65M
Vertex Pharmaceuticals VRTX:US $ 1087.41M 1092.53M
YTE INCY:US $ 262.16M 92.39M